Company Overview and News
I admit, I’ve been a dinosaur when it comes to many things, among them home security monitoring. For going on 20 years, I’ve paid a modest monthly fee for someone at a central monitoring station to call the police and me if a sensor in my home has been tripped indicating a possible intruder.
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including General Dynamics (GD), Verizon Communications (VZ) and American International Group (AIG). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
When it comes to understanding the secular trends in technology, Microsoft Corporation (NASDAQ:MSFT) CEO Satya Nadella has been spot on. When he took the helm of the company in 2014, he took swift action to focus on the cloud. And yes, the results have been standout. Note that during the past three years, the compound annual growth rate for Microsoft stock has been a sizzling 32.63%.
On Apr 4, Zacks Investment Research upgraded Johnson Controls International plc (JCI - Free Report) to a Zacks Rank #2 (Buy). Going by the Zacks model, companies carrying a Zacks Rank of 2 have higher chances of outperforming the broader market.
The auto sector staged a comeback in March after sagging sales performance in February. A majority of automakers reported a rise in their March U.S. sales. A robust economy, product launches and fat discounts enabled auto players to witness a year-over-year rise in new vehicle sales. Even concerns over high interest rates and elevated gasoline prices could not deter Americans’ new-found liking for sport utility vehicles (SUVs) and pickup trucks, albeit at the cost of sedans and passenger cars.
Johnson Controls International plc (JCI - Free Report) reportedly acquired Nashville-based Smartvue Corporation. The acquired company is a provider of Internet of Things (IoT), and videos that empower IoT video services and cloud video surveillance. The terms of the deal have not been made public yet.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
If the St. Patrick’s Day observances have investors pondering opportunities in the Emerald Isle, there are a few things to know. First, Ireland has been known for some time for its low corporate tax rate, which even prompted some U.S. companies to move their headquarters there. That was often accomplished by means of a so-called tax inversion, in which a merger or acquisition allows the company to claim the headquarters of the Irish (or other foreign) partner as its own.
Johnson Controls International plc (JCI - Free Report) announced to mull over strategic alternatives for the Power Solutions unit that produces advanced battery technology solutions for vehicles. The Cork, the Ireland-based diversified technology company is weighing on alternatives for the Power Solutions business to emphasize more on its core products of building technology. Notably, Johnson Controls functions through two segments – Building Technologies & Solutions and Power Solutions.
Industrial firm Johnson Controls International PLC (NYSE: JCI) announced this morning that the company is conducting a strategic review of its Power Solutions business. The Ireland-based company supplies car batteries under a variety of brand names to customers including Walmart, Costco and Advanced Auto Parts.
(Reuters) - Johnson Controls International Plc (JCI.N) said on Monday it would explore strategic alternatives for its power solutions business, which makes lead-acid automotive batteries for passenger cars and light trucks.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...
as of ET